Brown Advisory Securities, LLC - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 38 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Brown Advisory Securities, LLC ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2022$12,000
-65.7%
28,0000.0%0.01%
-45.0%
Q1 2022$35,000
-2.8%
28,0000.0%0.02%
+33.3%
Q4 2021$36,000
-37.9%
28,0000.0%0.02%
-11.8%
Q3 2021$58,000
+31.8%
28,0000.0%0.02%
+142.9%
Q2 2021$44,000
-29.0%
28,0000.0%0.01%
-36.4%
Q1 2021$62,000
-10.1%
28,0000.0%0.01%
-8.3%
Q4 2020$69,0000.0%28,0000.0%0.01%
-14.3%
Q3 2020$69,000
-25.0%
28,0000.0%0.01%
-30.0%
Q2 2020$92,000
+53.3%
28,0000.0%0.02%
+33.3%
Q1 2020$60,000
-3.2%
28,0000.0%0.02%0.0%
Q4 2019$62,000
+21.6%
28,0000.0%0.02%
+7.1%
Q3 2019$51,000
+24.4%
28,0000.0%0.01%
+27.3%
Q2 2019$41,000
-25.5%
28,0000.0%0.01%
-15.4%
Q1 2019$55,000
+25.0%
28,0000.0%0.01%
+62.5%
Q4 2018$44,000
-36.2%
28,0000.0%0.01%
-27.3%
Q3 2018$69,000
-26.6%
28,0000.0%0.01%
-31.2%
Q2 2018$94,000
-20.3%
28,0000.0%0.02%
-27.3%
Q1 2018$118,000
+28.3%
28,0000.0%0.02%
+22.2%
Q4 2017$92,000
-14.0%
28,0000.0%0.02%
-21.7%
Q3 2017$107,000
-13.0%
28,0000.0%0.02%
-17.9%
Q2 2017$123,000
+20.6%
28,0000.0%0.03%
+12.0%
Q1 2017$102,000
+36.0%
28,0000.0%0.02%
+25.0%
Q4 2016$75,000
-17.6%
28,0000.0%0.02%
-25.9%
Q3 2016$91,000
-3.2%
28,0000.0%0.03%
-6.9%
Q2 2016$94,000
+38.2%
28,0000.0%0.03%
+31.8%
Q1 2016$68,000
-26.1%
28,0000.0%0.02%
-29.0%
Q4 2015$92,00028,0000.03%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Corrigan Financial, Inc. 302,252$102,7660.03%
Virtu Financial LLC 13,324$50.00%
Bleakley Financial Group, LLC 80,000$27,2000.00%
Beaird Harris Wealth Management, LLC 24,400$8,2960.00%
One Day In July LLC 10,000$3,4000.00%
Cubic Asset Management, LLC 10,000$3,4000.00%
WMS Partners, LLC 18,000$6,1200.00%
Simplicity Solutions, LLC 80,000$27,2000.00%
WELLS FARGO & COMPANY/MN 3,296$1,1210.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders